Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

345.73
+3.441.00%
Post-market: 351.005.27+1.52%19:59 EDT
Volume:355.25K
Turnover:122.48M
Market Cap:7.71B
PE:-26.98
High:348.34
Open:340.98
Low:339.31
Close:342.29
52wk High:377.46
52wk Low:200.63
Shares:22.29M
Float Shares:11.00M
Volume Ratio:0.68
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8155
EPS(LYR):-21.9007
ROE:-36.30%
ROA:-18.31%
PB:11.07
PE(LYR):-15.79

Loading ...

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Madrigal Pharmaceuticals (MDGL) and Ligand Pharma (LGND)

TIPRANKS
·
Feb 27

Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA

TIPRANKS
·
Feb 27

Madrigal price target raised to $405 from $400 at H.C. Wainwright

TIPRANKS
·
Feb 27

High Growth Tech Stocks In US For February 2025

Simply Wall St.
·
Feb 27

U.S. RESEARCH ROUNDUP-Abbvie, Freeport-McMoran, Goldman Sachs

Reuters
·
Feb 27

Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...

GuruFocus.com
·
Feb 27

Madrigal’s Financial Vulnerability: Overreliance on Specialty Pharmacies Threatens Revenue Stability

TIPRANKS
·
Feb 27

Q4 2024 Madrigal Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
Feb 27

JMP Securities Reaffirms Their Buy Rating on Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
Feb 27

Madrigal Pharmaceuticals Shares Jump After Q4 Beat, Release of New Data on Steatohepatitis Drug

MT Newswires Live
·
Feb 27

Madrigal Q4 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

Zacks
·
Feb 27

Madrigal Pharmaceuticals Phase 3 data ‘encouraging,’ says UBS

TIPRANKS
·
Feb 27

BUZZ-Madrigal rises on robust sales and long-term data for liver disease drug

Reuters
·
Feb 26

Why Madrigal Pharmaceuticals Stock Is Soaring Today

Motley Fool
·
Feb 26

Stock Track | Madrigal Pharmaceuticals Soars 8.24% in Pre-market on Promising Rezdiffra Data and Better-Than-Expected Q4 Results

Stock Track
·
Feb 26

Madrigal Pharmaceuticals Says Steatohepatitis Drug Shows 'Marked Reductions' in Patients' Liver Stiffness

MT Newswires Live
·
Feb 26

Madrigal Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Sector Update: Health Care Stocks Decline Pre-Bell Wednesday

MT Newswires Live
·
Feb 26

Stock Track | Madrigal Pharmaceuticals Soars 6.63% Pre-Market on Positive Q4 Results and Promising Rezdiffra Data

Stock Track
·
Feb 26

Madrigal (MDGL) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
Feb 26